Welcome to our dedicated page for Under Armour SEC filings (Ticker: UA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Under Armour, Inc. Class C Common Stock (UA) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, including current reports on Form 8-K and other key documents filed with the U.S. Securities and Exchange Commission. Under Armour, incorporated in Maryland and headquartered in Baltimore, files under Commission File Number 001-33202 and reports its financial results in accordance with U.S. GAAP, often accompanied by non-GAAP metrics such as "adjusted" and "currency neutral" figures.
For UA, Form 8-K filings are particularly relevant for tracking material events. Recent 8-Ks describe an expanded fiscal 2025 restructuring plan, including the Board-approved increase in expected restructuring and related charges, the inclusion of the Curry Brand separation, and the anticipated timing of completion. Other 8-Ks cover quarterly financial results, scheduled earnings conference calls, and significant executive changes, such as the planned appointment of a new Executive Vice President and Chief Financial Officer and the transition of the current CFO to a senior advisor role, as well as the departure of the Chief Product Officer and his subsequent advisory arrangement.
Through this filings page, users can review how Under Armour discloses costs associated with exit or disposal activities, restructuring charges, transformation expenses, and capital structure actions. The company’s filings also include extensive forward-looking statements and risk factor discussions that outline potential impacts from economic conditions, tariffs, competition, supply chain costs, global expansion, technology systems, access to capital, foreign currency, data security, public health emergencies, and litigation or other proceedings.
Stock Titan enhances these filings with AI-powered summaries that highlight the main points of each document, helping readers quickly understand the significance of new 8-Ks, annual and quarterly reports, and other submissions. Real-time updates from EDGAR, combined with simplified explanations of complex disclosures such as restructuring plans, executive compensation arrangements, and debt offerings, allow investors to analyze Under Armour’s regulatory history and ongoing obligations more efficiently.
Under Armour, Inc. reported that Chief Product Officer and named executive officer Yassine Saidi will step down from his role on February 2, 2026 to pursue other opportunities. He will remain involved with the company’s product creation organization through February 2027 as Special Advisor, Design and Expression under a consulting services agreement.
Under this agreement, Mr. Saidi is expected to receive approximately $375,000 per quarter, continued vesting of his outstanding equity awards during the consulting term, and certain tax support services. The company also issued a press release detailing his departure and other executive changes, which is included as an exhibit to this report.
BlackRock, Inc. has filed an amended beneficial ownership report showing a significant stake in Under Armour, Inc. Class A stock. BlackRock reports beneficial ownership of 20,088,049 Class A shares, representing 10.6% of the class as of 12/31/2025. It has sole power to vote 19,779,684 shares and sole power to dispose of 20,088,049 shares, with no shared voting or dispositive power. The filing states the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Under Armour. One underlying fund, iShares Core S&P Small-Cap ETF, holds more than five percent of the outstanding common stock.
Under Armour, Inc. director Patrick Whitesell reported receiving Class C Common Stock through deferred director compensation. On 01/02/2026, he acquired 4,930.97 shares of Class C Common Stock at a price of
Under Armour, Inc. director Robert John Sweeney reported routine equity compensation. On 01/02/2026, he acquired 5,424.06 shares of Class C common stock at $0 per share, reflecting director fees deferred as deferred stock units under the company’s Fiscal Year 2025 Non-Employee Director Compensation Plan. Following this transaction, he beneficially owns 175,429.96 shares of Class C common stock in direct form. The filing also notes that no Class A common stock (UAA) is beneficially owned.
Under Armour, Inc. director David W. Gibbs reported an equity award in the company’s Class C common stock on 01/02/2026. He acquired 5,670.61 shares of Class C common stock at a price of $0, recorded as deferred stock units under the Under Armour, Inc. Fiscal Year 2025 Non-Employee Director Compensation Plan. Following this transaction, he beneficially owns 167,921.74 shares of Class C common stock directly and an additional 50,000 shares of Class C common stock indirectly through the SJG Irrevocable Trust. The report also states that no Class A common stock (UAA) is beneficially owned.
Under Armour, Inc. director Dawn N. Fitzpatrick reported an acquisition of Class C common stock on 01/02/2026. The filing shows she acquired 5,424.06 shares of Class C common stock at a stated price of $0, reflecting director fees deferred into stock units under the company’s Fiscal Year 2025 Non-Employee Director Compensation Plan. After this transaction, she beneficially owned 175,429.96 shares of Class C common stock in direct form. The filing also notes that no Class A Common Stock (UAA) is beneficially owned.
Under Armour director reports deferred stock unit grant. Director Carolyn N. Everson elected to defer director fees into Class C common stock units of Under Armour, Inc. on 01/02/2026. She acquired 986.19 Class C common stock units at a price of $0, reflecting compensation rather than an open-market purchase. Following this transaction, she beneficially owns 107,538.28 Class C common stock units directly. The disclosure notes that no Class A Common Stock (UAA) is beneficially owned.
Under Armour director equity grant reported in Form 4
Under Armour, Inc. director Mohamed El-Erian reported receiving 4,437.87 shares of Class C common stock on 01/02/2026. The filing states these were director fees deferred as deferred stock units under the company’s Fiscal Year 2025 Non-Employee Director Compensation Plan and were acquired at a stated price of $0 per share, reflecting compensation rather than an open-market purchase.
Following this transaction, El-Erian beneficially owned 212,181.31 shares of Under Armour Class C common stock and 111,650 shares of Class A common stock, all held directly. The filing is signed by an attorney-in-fact on his behalf.
Under Armour director Douglas E. Coltharp reported a routine equity compensation transaction. On 01/02/2026, he acquired 7,026.63 shares of Class C Common Stock at a price of $0, reflecting director fees deferred as deferred stock units under the Under Armour, Inc. Fiscal Year 2025 Non-Employee Director Compensation Plan. After this transaction, he beneficially owned 311,328.86 shares of Class C Common Stock directly, with additional indirect holdings in various trusts and UTMA accounts, and also held direct and indirect positions in Class A Common Stock. The filing is made as a Form 4 by a director and does not reflect an open-market purchase or sale for cash.
Under Armour, Inc. investors are informed that V. Prem Watsa and a group of Fairfax-affiliated entities have filed a Schedule 13D reporting significant ownership of the company’s Class A common stock. The group beneficially owns 41,958,923 Class A Shares, representing 22.2% of the class, based on 188,834,386 Class A Shares outstanding as of October 31, 2025.
The filing states that the Class A Shares were purchased with cash on hand from existing investment portfolios and were acquired for investment purposes. The Fairfax-affiliated entities indicate they may buy additional Under Armour securities or sell some or all of their holdings depending on price, market conditions, availability of funds and other factors, but they report no present intention to pursue the transactions typically listed in Item 4 of Schedule 13D, such as mergers or other control-related actions.
FAQ
What is the current stock price of Under Armour (UA)?
What is the market cap of Under Armour (UA)?
